NSE : INDOCO.NS

Indoco Remedies Limited

$243.42 INR

$5.27 (2.21%)

Volume
49.96K
Average Volume
424.71K
Market Capitalization
$22.44B
P/E Ratio
-22.66
Dividend Yield
0.08%
Price Target
Year High
$332.20
Year Low
$162.19
Day High
—
Day Low
—
Payout Ratio
-$0.02
Current Ratio
$1.13
Company Overview

NSE

Aditi Kare Panandikar

Drug Manufacturers - Specialty & Generic

Healthcare

INDOCO.NS

6000

IN

INR

https://www.indoco.com

91 22 6287 1000

Y3939C106

N/A

Liquidity Metrics

1.16

1.13

0.75

0.03

-0.02

Sales & Valuation

$18.45B

1.23

2.18

41.52

6.42

Profitability

-$10.69

-$987M

-5.33%

-5.85%

-9.94%

-3.75%

P/E Metrics

-22.66

0.55

0.55

Analyst Price Target & Rating

Strong Sell

1/5

0 Analysts

%

Financial Health Scores

1.60

6/9

$1.41B

$25.93B

$16.61B

$209.1M

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Kavita Inamdar Chief Technical Officer
Dileep Mahajan Vice President of Operations
Pramod Ghorpade Chief Financial Officer
Ajay Karajagi President of Sales & Marketing
Rajan Saawant Vice President of Corporate HR
Rajesh Usgaonker Chief Marketing Officer
Sundeep Vasant Bambolkar Joint MD & Executive Director
Suresh Govind Kare Non-Executive Chairman & Whole time Director
Aditi Milind Panandikar MD & Executive Director
Ramanathan Hariharan Head of Legal, Company Secretary & Compliance Officer
Poll Results

No votes yet today — be the first to share your view!

About Indoco Remedies Limited (NSE:INDOCO.NS) Stock

Indoco Remedies Limited, an Indian pharmaceutical company founded in Mumbai in 1945 (originally known as Indo Continental Trading Company), operates globally, manufacturing and distributing a broad spectrum of finished drug formulations and active pharmaceutical ingredients (APIs). The company's extensive product portfolio addresses diverse therapeutic areas: Respiratory conditions: with offerings like Karvol Plus, Febrex Plus, and Tuspel. Oral and dental care (stomatologicals): including Sensodent-K, Sensoform Toothpaste, the Rexidin series, and Snowdent. Gastrointestinal ailments: featuring products such as Carmicide, Cyclopam, and Nosic. Pain relief/analgesics: exemplified by Lignox and T-lac. Ophthalmic and otic solutions: comprising items like Renolen, Dexoren – S, and the Mofloren ra ... nge. Vitamins, minerals, and nutritional supplements: such as Methycal, MCBM DHA, and Apispur. Urological treatments: including Carmicide and Cital. Dermatological preparations: like Cloben G and Scabex. Anti-infective agents: represented by ATM. Blood-related therapies: such as Hemsyl. Gynecological health products: including MCBM 69 and D Chiro. Anti-haemorrhoidal treatments: with Spear. Beyond its pharmaceutical manufacturing, Indoco Remedies provides comprehensive analytical services. These include impurity profiling, particle size analysis, heavy metal analysis, polymorphism studies, compatibility and stability assessments (like extractables/leachables and lyophilization), and advanced chromatographic method development and validation. Furthermore, the company offers a suite of engineering and project management services. This covers architectural and structural design, mechanical and electrical engineering, lighting solutions, control system integration, piping design, data transfer systems, and holistic project and construction management for process facilities. Indoco Remedies serves a wide range of medical professionals, from general practitioners and pediatricians to specialized consultants like dentists, cardiologists, diabetologists, endocrinologists, gynaecologists, and ophthalmologists.

Frequently Asked Questions

What is the current Indoco Remedies Limited (INDOCO.NS) stock price?

Indoco Remedies Limited(NSE:INDOCO.NS) stock price is $243.42 in the last trading session. During the trading session, INDOCO.NS stock reached the peak price of $332.2 while $162.19 was the lowest point it dropped to. The percentage change in INDOCO.NS stock occurred in the recent session was 2.21% while the dollar amount for the price change in INDOCO.NS stock was $5.27.

INDOCO.NS's industry and sector of operation?

The NSE listed INDOCO.NS is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of INDOCO.NS?

Kavita Inamdar | Chief Technical Officer
Dileep Mahajan | Vice President of Operations
Pramod Ghorpade | Chief Financial Officer
Ajay Karajagi | President of Sales & Marketing
Rajan Saawant | Vice President of Corporate HR

How many employees does INDOCO.NS have?

Number of INDOCO.NS employees currently stands at 6000. INDOCO.NS operates from Indoco House, Mumbai, MA 400098, IN.

Link for INDOCO.NS official website?

Official Website of INDOCO.NS is: https://www.indoco.com

How do I contact INDOCO.NS?

INDOCO.NS could be contacted at phone #91 22 6287 1000 and can also be accessed through its website. INDOCO.NS operates from Indoco House, Mumbai, MA 400098, IN.

How many shares of INDOCO.NS are traded daily?

The average number of INDOCO.NS shares traded daily for last 3 months was 424.71K.

What is the market cap of INDOCO.NS currently?

The market value of INDOCO.NS currently stands at $22.44B with its latest stock price at $243.42